Carvedilol hydrobromide
    1.
    发明授权
    Carvedilol hydrobromide 有权
    卡维地洛氢溴酸盐

    公开(公告)号:US07649010B2

    公开(公告)日:2010-01-19

    申请号:US11548368

    申请日:2006-10-11

    IPC分类号: A61K31/403 C07D209/82

    CPC分类号: C07D209/88

    摘要: The present invention relates to a salt of carvedilol, corresponding compositions containing such a carvedilol salt or corresponding solvates thereof, and/or methods of using the aforementioned compound(s) in the treatment of certain disease states in mammals, in particular man. The present invention further relates to a novel crystalline form of carvedilol hydrobromide, which is the hydrobromide salt of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol, and/or other carvedilol solvates thereof, compositions containing salts or solvates of carvedilol hydrobromide, and methods of using the aforementioned compound(s) to treat hypertension, congestive heart failure, and angina, etc.

    摘要翻译: 本发明涉及卡维地洛的盐,含有这种卡维地洛盐或其相应溶剂合物的相应组合物,和/或使用上述化合物治疗哺乳动物,特别是人中某些疾病状态的方法。 本发明还涉及1-(咔唑-4-基氧基-3 - [[2-(邻甲氧基苯氧基)乙基]氨基] -2-丙醇的氢溴酸盐的新型结晶形式的卡维地洛氢溴酸盐,以及 /或其他卡维地洛溶剂化物,含有卡维地洛氢溴酸盐的盐或溶剂合物的组合物,以及使用上述化合物治疗高血压,充血性心力衰竭和心绞痛等的方法。